益生菌治疗肝脏疾病的临床研究进展  

Progress in clinical researches on Probiotics in treatment of liver disease

作　　者：王春颖 邢会霞 程利敏 龚虹 李晓军 袁虹 王海霞 马跃英 刘彦民 

机构地区：[1]内蒙古双奇药业股份有限公司,内蒙古呼和浩特010010

出　　处：《中国微生态学杂志》2015年第11期1355-1358,共4页Chinese Journal of Microecology

摘　　要：肝脏疾病的危害较大,采用化学药品治疗的不良反应较大,若采用益生菌进行治疗将大大减少不良反应。本文介绍了益生菌治疗肝脏疾病的机制以及国内外利用益生菌在肝脏疾病方面的临床研究进展。Liver disease can cause severe damage to human health,but treatments with chemical drugs are often associated with serious adverse reactions.In contrast,the use of probiotics in treatment of liver disease will greatly reduce adverse reactions.This article describes the mechanisms of probiotics in treatment of liver disease and the progress in clinical researches on probiotics in teretment of liver disease at home and abroad.

关 键 词：益生菌 肝脏疾病 临床研究 

分 类 号：R575[医药卫生—消化系统]